264 related articles for article (PubMed ID: 19074065)
1. Paroxysmal nocturnal hemoglobinuria: an historical overview.
Parker CJ
Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
[TBL] [Abstract][Full Text] [Related]
2. [History of paroxysmal nocturnal hemoglobinuria].
Chrobák L
Acta Medica (Hradec Kralove) Suppl; 2002; 45(1):11-7. PubMed ID: 19569576
[TBL] [Abstract][Full Text] [Related]
3. The membrane abnormalities in paroxysmal nocturnal hemoglobinuria (PNH).
Rosse WF; Adams JP
Prog Clin Biol Res; 1979; 30():457-61. PubMed ID: 531036
[TBL] [Abstract][Full Text] [Related]
4. The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment.
Risitano AM; Notaro R; Pascariello C; Sica M; del Vecchio L; Horvath CJ; Fridkis-Hareli M; Selleri C; Lindorfer MA; Taylor RP; Luzzatto L; Holers VM
Blood; 2012 Jun; 119(26):6307-16. PubMed ID: 22577173
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585
[TBL] [Abstract][Full Text] [Related]
6. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
Jenkins DE; Hartmann RC; Kerns AL
J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
[TBL] [Abstract][Full Text] [Related]
7. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the proportion of paroxysmal nocturnal hemoglobinuria (PNH) III-erythrocytes and the frequency of exacerbated hemoglobinuria in PNH.
Shichishima T; Terasawa T; Uchida T; Maruyama Y
Eur J Haematol; 1991 Sep; 47(3):235-6. PubMed ID: 1915809
[No Abstract] [Full Text] [Related]
9. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
Parker CJ; Stone OL; Bernshaw NJ
J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
Parker CJ; Wiedmer T; Sims PJ; Rosse WF
J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
[TBL] [Abstract][Full Text] [Related]
11. Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease.
Halperin JA; Nicholson-Weller A
Complement Inflamm; 1989; 6(1):65-72. PubMed ID: 2650991
[TBL] [Abstract][Full Text] [Related]
12. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
13. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
[TBL] [Abstract][Full Text] [Related]
14. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K
J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278
[TBL] [Abstract][Full Text] [Related]
15. Paroxysmal nocturnal haemoglobinuria.
Rosse WF; Parker CJ
Clin Haematol; 1985 Feb; 14(1):105-25. PubMed ID: 3886232
[TBL] [Abstract][Full Text] [Related]
16. Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria.
Chow FL; Hall SE; Rosse WF; Telen MJ
Blood; 1986 Apr; 67(4):893-7. PubMed ID: 3955235
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of various therapies on complement-sensitive erythrocytes in paroxysmal nocturnal hemoglobinuria.
Shichishima T; Saitoh Y; Noji H; Terasawa T; Maruyama Y
Int J Hematol; 1996 Jun; 63(4):291-302. PubMed ID: 8762812
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
Logue GL; Rosse WF; Adams JP
J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
[TBL] [Abstract][Full Text] [Related]
19. [Influencing of properidin activity by erythrocyte stroma, with a contribution to hemolysis problem in paroxysmal nocturnal hemoglobinuria: Marchiafava-Micheli anemia].
MARTIN H; VOSS J
Vox Sang; 1957 Jul; 2(3):201-17. PubMed ID: 13468368
[No Abstract] [Full Text] [Related]
20. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH).
Nakakuma H
Am J Hematol; 1996 Sep; 53(1):22-9. PubMed ID: 8813092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
